AgingResearch.NewsJoin free

Actigraph-gt3x+

Intervention

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 2 countries
  • Funder: Edge Hill University
  • Humans1

Associations

2

Moderate-to-vigorous physical activity classification

upin humans1

1 study

  1. Actigraph-gt3x+ predicts moderate-to-vigorous physical activity classification in humans (AUC 0.94).

    “and 0.90 for AG SB and 0.94 for AG MVPA”

    Human triallaboratory calibration analysisn = 34

    Evaluation of wrist and hip sedentary behaviour and moderate-to-vigorous physical activity raw acceleration cutpoints in older adults

    Journal of sports sciences17 Dec 2018

Sedentary behaviour classification

upin humans1

1 study

  1. Actigraph-gt3x+ predicts sedentary behaviour classification in humans (AUC 0.90).

    “and 0.90 for AG SB and 0.94 for AG MVPA”

    Human triallaboratory calibration analysisn = 34

    Evaluation of wrist and hip sedentary behaviour and moderate-to-vigorous physical activity raw acceleration cutpoints in older adults

    Journal of sports sciences17 Dec 2018

Latest

Related